“The current condition has uncovered some structural weaknesses in the EU’s medicines source chain along with a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides stated. She encouraged that provide chain concerns be tackled within an EU pharmaceutical tactic envisioned to get launched